Dihong H. Tang

283 Tongzipo Road
Changsha, 410000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study.

TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study.

Journal: Cancer cell
Published: April 29, 2025

Single-cell profiling reveals the intratumor heterogeneity and immunosuppressive microenvironment in cervical adenocarcinoma.

Single-cell profiling reveals the intratumor heterogeneity and immunosuppressive microenvironment in cervical adenocarcinoma.

Journal: eLife
Published: March 11, 2025

Targeting Mitochondrial Cholesterol Efflux via TCF21/ABCA10 Pathway to Enhance Cisplatin Efficacy in Ovarian Cancer.

Targeting Mitochondrial Cholesterol Efflux via TCF21/ABCA10 Pathway to Enhance Cisplatin Efficacy in Ovarian Cancer.

Journal: Biochemical genetics
Published: May 14, 2024

QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial.

QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial.

Journal: Journal of gynecologic oncology
Published: September 03, 2023

Reversal of the immunosuppressive tumor microenvironment via platinum-based neoadjuvant chemotherapy in cervical cancer.

Reversal of the immunosuppressive tumor microenvironment via platinum-based neoadjuvant chemotherapy in cervical cancer.

Journal: Cancer pathogenesis and therapy
Published: May 13, 2023

SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, for Recurrent or Metastatic Cervical Cancer: A Clinical Expansion Cohort of a Phase I Study.

SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, for Recurrent or Metastatic Cervical Cancer: A Clinical Expansion Cohort of a Phase I Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 01, 2022

Selection and effects of flap/myocutaneous flap repair methods for the defect after perineum tumor resection

Selection and effects of flap/myocutaneous flap repair methods for the defect after perineum tumor resection

Journal: Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns
Published: June 30, 2020

Long non-coding RNA: A recently accentuated molecule in chemoresistance in cancer.

Long non-coding RNA: A recently accentuated molecule in chemoresistance in cancer.

Journal: Cancer metastasis reviews
Published: June 29, 2020

Identification and characterization of a subpopulation of CD133+ cancer stem-like cells derived from SK-UT-1 cells.

Identification and characterization of a subpopulation of CD133+ cancer stem-like cells derived from SK-UT-1 cells.

Journal: Cancer cell international
Published: August 27, 2019

Label-free detection of miRNA cancer markers based on terminal deoxynucleotidyl transferase-induced copper nanoclusters.

Label-free detection of miRNA cancer markers based on terminal deoxynucleotidyl transferase-induced copper nanoclusters.

Journal: Analytical biochemistry
Published: April 30, 2019

MiR-218 produces anti-tumor effects on cervical cancer cells in vitro.

MiR-218 produces anti-tumor effects on cervical cancer cells in vitro.

Journal: World journal of surgical oncology
Published: June 10, 2018

Isolation, Culture and Identification of Choriocarcinoma Stem-Like Cells from the Human Choriocarcinoma Cell-Line JEG-3.

Isolation, Culture and Identification of Choriocarcinoma Stem-Like Cells from the Human Choriocarcinoma Cell-Line JEG-3.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: April 07, 2016
Showing 1-12 of 14

Last Updated: 09/26/2026